Variant report
Variant | esv3395234 |
---|---|
Chromosome Location | chr2:51985648-51990546 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CHAC2-4 | chr2:51989227-51989312 | ENSG00000231918.1 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560258023 | chr2:51985656-51985657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs145548651 | chr2:51985729-51985730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs4971575 | chr2:51985735-51985736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs372562600 | chr2:51985755-51985756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs556269995 | chr2:51985764-51985765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs145421112 | chr2:51985769-51985770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs35161129 | chr2:51985778-51985779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs536142519 | chr2:51985786-51985787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs542815907 | chr2:51986637-51986638 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs560786376 | chr2:51986645-51986646 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs148301134 | chr2:51986720-51986721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs28965176 | chr2:51986725-51986726 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs190130078 | chr2:51986762-51986763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs375870414 | chr2:51986807-51986808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs574177020 | chr2:51986856-51986857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs567161762 | chr2:51986887-51986888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs2176221 | chr2:51986989-51986990 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs182225173 | chr2:51987003-51987004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs187297205 | chr2:51987023-51987024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs538379291 | chr2:51987026-51987027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs556589989 | chr2:51987047-51987048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs28965177 | chr2:51987053-51987054 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs539039563 | chr2:51987086-51987087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs28965178 | chr2:51987111-51987112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs180875721 | chr2:51987116-51987117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs542429658 | chr2:51987152-51987153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs554783894 | chr2:51987167-51987168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs576047027 | chr2:51987185-51987186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs17864601 | chr2:51987203-51987204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs184880632 | chr2:51987204-51987205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs28965179 | chr2:51987205-51987206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs531938855 | chr2:51987207-51987208 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs545786454 | chr2:51987252-51987253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs540638919 | chr2:51987254-51987255 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs569883156 | chr2:51987281-51987282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs397825810 | chr2:51987292-51987293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs28965181 | chr2:51987293-51987294 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs11563264 | chr2:51987301-51987302 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs139951575 | chr2:51987339-51987340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs35750267 | chr2:51987390-51987391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs145589927 | chr2:51987413-51987414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs150673385 | chr2:51987436-51987437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs571779849 | chr2:51987444-51987445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs28965182 | chr2:51987447-51987448 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs574698007 | chr2:51987450-51987451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs562197750 | chr2:51987463-51987464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs547791655 | chr2:51987482-51987483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs28965183 | chr2:51987508-51987509 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs538870108 | chr2:51987520-51987521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs190132284 | chr2:51987565-51987566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:51984400-51985800 | Enhancers | Hela-S3 | cervix |
2 | chr2:51986600-51987200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
3 | chr2:51987200-51987800 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
4 | chr2:51987800-51988000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |